Indomethacin therapy in hydramnios.
J Postgrad Med
;
2000 Jul-Sep; 46(3): 176-8
Article
Dans Anglais
| IMSEAR
| ID: sea-115270
ABSTRACT
AIM:
The use of indomethacin in treatment of hydramnios was evaluated. SUBJECTS &METHODS:
Twelve patients with symptomatic hydramnios were treated with indomethacin (2.2- 3.0 mg/kg body weight/day).RESULTS:
The treatment was started at a gestational age of 31.17-/+7.94 weeks and continued for 3.74-/+2.3 weeks. Eleven patients responded to the therapy both subjectively and objectively and pregnancies were prolonged by 4.6-/+3.1 weeks (range 0.1-10 weeks). Five women had term deliveries. Six patients had a favourable perinatal outcome. Four patients who had a known congenital anomaly in the foetus, delivered stillborn babies or had an early neonatal death. One patient who did not follow up after commencing therapy delivered a full-term stillbirth. One patient delivered within 1 day of starting therapy. Indomethacin therapy caused no maternal complications.CONCLUSION:
Indomethacin was effective in the management of hydramnios and preventing it's complications.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Indice de gravité de la maladie
/
Femelle
/
Humains
/
Grossesse
/
Calendrier d'administration des médicaments
/
Issue de la grossesse
/
Anti-inflammatoires non stéroïdiens
/
Indométacine
/
Études de suivi
/
Échographie prénatale
Type d'étude:
Etude diagnostique
/
Étude observationnelle
/
Étude pronostique
langue:
Anglais
Texte intégral:
J Postgrad Med
Année:
2000
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS